Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1641-1650 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|May 25, 2023
Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2Meghan M Verstraete, Florian Heinkel, Janessa Li, et al.
Mabs|January 27, 2015
Clinical considerations for the development of biosimilars in oncologyMark A Socinski, Giuseppe Curigliano, Ira Jacobs, et al.
Mabs|January 27, 2015
Improving target cell specificity using a novel monovalent bispecific IgG designYariv Mazor, Vaheh Oganesyan, Chunning Yang, et al.
Mabs|January 27, 2015
Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cellsJake Chng, Tianhua Wang, Rui Nian, et al.
Mabs|January 22, 2015
De novo isolation of antibodies with pH-dependent binding propertiesPauline Bonvin, Sophie Venet, Gaëlle Fontaine, et al.
Mabs|August 7, 2012
The new ParaDIgm: IgM from bench to clinic: November 15-16, 2011, Frankfurt, GermanySherif Hanala
Mabs|August 7, 2012
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USAMitchell Ho, Ivor Royston, Alain Beck
Mabs|April 16, 2015
Reconstructing and mining the B cell repertoire with ImmunediveRsityBernardo Cortina-Ceballos, Elizabeth Ernestina Godoy-Lozano, Hugo Sámano-Sánchez, et al.
Mabs|February 14, 2015
Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potencyYun Yang, Qingcheng Guo, Mao Xia, et al.
Mabs|March 10, 2015
Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma modelJonathan Nambiar, Adam W Clarke, Doris Shim, et al.
Pageof 178

Showing results (1641-1650 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|May 25, 2023
Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2Meghan M Verstraete, Florian Heinkel, Janessa Li, et al.
Mabs|January 27, 2015
Clinical considerations for the development of biosimilars in oncologyMark A Socinski, Giuseppe Curigliano, Ira Jacobs, et al.
Mabs|January 27, 2015
Improving target cell specificity using a novel monovalent bispecific IgG designYariv Mazor, Vaheh Oganesyan, Chunning Yang, et al.
Mabs|January 27, 2015
Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cellsJake Chng, Tianhua Wang, Rui Nian, et al.
Mabs|January 22, 2015
De novo isolation of antibodies with pH-dependent binding propertiesPauline Bonvin, Sophie Venet, Gaëlle Fontaine, et al.
Mabs|August 7, 2012
The new ParaDIgm: IgM from bench to clinic: November 15-16, 2011, Frankfurt, GermanySherif Hanala
Mabs|August 7, 2012
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USAMitchell Ho, Ivor Royston, Alain Beck
Mabs|April 16, 2015
Reconstructing and mining the B cell repertoire with ImmunediveRsityBernardo Cortina-Ceballos, Elizabeth Ernestina Godoy-Lozano, Hugo Sámano-Sánchez, et al.
Mabs|February 14, 2015
Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potencyYun Yang, Qingcheng Guo, Mao Xia, et al.
Mabs|March 10, 2015
Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma modelJonathan Nambiar, Adam W Clarke, Doris Shim, et al.
Pageof 178